Graft-induced dyskinesia (GID) is a serious complication induced by dopamine (DA) cell transplantation in parkinsonian patients. We have recently shown that DA D2 receptor blockade produces sticking blockade of dyskinesia induced by amphetamine in grafted 6-OHDA-lesioned rats, a model of GID. This study was designed to investigate whether blockade of DA D1 receptors could produce similar outcome, and to see whether the effect of these treatments in grafted rats was specific for dyskinesia induced by amphetamine, or could also influence L-DOPA-induced dyskinesia (LID). L-DOPA-primed rats received transplants of fetal DA neurons into the DA-denervated striatum. Beginning at 20weeks after transplantation rats were subjected to pharmacological ...
Clinical trials evaluating transplantation of fetal tissue for the treatment of Parkinson's disease ...
Dyskinesia is a major side effect of an otherwise effective L-DOPA treatment in Parkinson's patients...
Transplantation of dopamine- (DA-) rich foetal ventral mesencephalic cells emerged as a promising th...
Graft-induced dyskinesia (GID) is a serious complication induced by dopamine (DA) cell transplantati...
Dyskinesia seen in the off-state, referred as graft-induced dyskinesia (GID), has emerged as a serio...
Foetal cell transplantation in patients with Parkinson’s disease can induce motor complications inde...
Intrastriatal transplants of embryonic ventral mesencephalon can cause dyskinesia in patients with P...
Intrastriatal transplants of embryonic ventral mesencephalon can cause dyskinesia in patients with P...
L-DOPA, the most effective drug to treat motor symptoms of Parkinson's disease, causes abnormal invo...
L-DOPA, the most effective drug to treat motor symptoms of Parkinson's disease, causes abnormal invo...
L-DOPA, the most effective drug to treat motor symptoms of Parkinson's disease, causes abnormal invo...
In some patients, graft-induced dyskinesia develops following intrastriatal transplantation of embry...
Clinical trials in patients with Parkinson's disease have shown that transplants of fetal mesencepha...
The observation that neural grafts can induce dyskinesias has severely hindered the development of a...
Background The risk of graft-induced dyskinesias (GIDs) presents a major challenge in progressing c...
Clinical trials evaluating transplantation of fetal tissue for the treatment of Parkinson's disease ...
Dyskinesia is a major side effect of an otherwise effective L-DOPA treatment in Parkinson's patients...
Transplantation of dopamine- (DA-) rich foetal ventral mesencephalic cells emerged as a promising th...
Graft-induced dyskinesia (GID) is a serious complication induced by dopamine (DA) cell transplantati...
Dyskinesia seen in the off-state, referred as graft-induced dyskinesia (GID), has emerged as a serio...
Foetal cell transplantation in patients with Parkinson’s disease can induce motor complications inde...
Intrastriatal transplants of embryonic ventral mesencephalon can cause dyskinesia in patients with P...
Intrastriatal transplants of embryonic ventral mesencephalon can cause dyskinesia in patients with P...
L-DOPA, the most effective drug to treat motor symptoms of Parkinson's disease, causes abnormal invo...
L-DOPA, the most effective drug to treat motor symptoms of Parkinson's disease, causes abnormal invo...
L-DOPA, the most effective drug to treat motor symptoms of Parkinson's disease, causes abnormal invo...
In some patients, graft-induced dyskinesia develops following intrastriatal transplantation of embry...
Clinical trials in patients with Parkinson's disease have shown that transplants of fetal mesencepha...
The observation that neural grafts can induce dyskinesias has severely hindered the development of a...
Background The risk of graft-induced dyskinesias (GIDs) presents a major challenge in progressing c...
Clinical trials evaluating transplantation of fetal tissue for the treatment of Parkinson's disease ...
Dyskinesia is a major side effect of an otherwise effective L-DOPA treatment in Parkinson's patients...
Transplantation of dopamine- (DA-) rich foetal ventral mesencephalic cells emerged as a promising th...